Charmaine Semeniuk
Psychiatry · San Diego, CANPI 1215012836
Payments from drug & device makers
Across 870 payments — averaging $10,185 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$4.2M
- Teva Pharmaceuticals USA, Inc.$2.1M
- AbbVie$1.3M
- E.r. Squibb & Sons, L.L.C.$411K
- Janssen Research & Development, LLC$183K
- Otsuka Pharmaceutical Development & Commercialization, Inc.$179K
- plus $446K from 17 others
Across 22 payments — averaging $149.18 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$2K
- Acadia Pharmaceuticals Inc$1K
- Eli Lilly$224
- Teva Pharmaceuticals USA, Inc.$58
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 349 | $4,172,629 |
| Teva Pharmaceuticals USA, Inc. | 210 | $2,140,435 |
| AbbVie(2 entities) | 124 | $1,328,933 |
| E.r. Squibb & Sons, L.L.C. | 12 | $411,067 |
| Janssen Research & Development, LLC | 23 | $183,360 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 11 | $178,797 |
| Alkermes, Inc. | 27 | $175,580 |
| Boehringer Ingelheim | 7 | $143,483 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $73,724 |
| Vanda Pharmaceuticals Inc. | 3 | $29,500 |
| Sage Therapeutics, LLC | 3 | $8,700 |
| H. Lundbeck A S | 2 | $3,964 |
| Boehringer Ingelheim International GmbH | 1 | $3,461 |
| Tolmar, Inc. | 1 | $2,874 |
| Avanir Pharmaceuticals, Inc. | 10 | $1,565 |
| Neurocrine Biosciences, Inc. | 24 | $899 |
| Otsuka America Pharmaceutical, Inc. | 23 | $775 |
| Axsome Therapeutics, Inc. | 8 | $588 |
| Lundbeck LLC | 9 | $149 |
| Sunovion Pharmaceuticals Inc. | 2 | $143 |
| Idorsia Pharmaceuticals US Inc | 1 | $129 |
| Johnson & Johnson | 4 | $94 |
| Acadia Pharmaceuticals Inc | 3 | $34 |
How this compares
$8,860,884 in reported general payments places this provider in the 95th percentile of 4,954 psychiatry providers in California.
Other psychiatry in San Diego
- Eric ChavezSan Diego$15.5M
- Jonathan MeyerSan Diego$2.3M
- Vishaal MehraSan Diego$1M
- Elly LeeIrvine$49.8M
- Daniel ChuehOrange$17.9M
- Lara ShirikjianTorrance$12.6M
- John DuffySanta Ana$12M
- Marina BusselPlaya Vista$12M
- Sherry SoefjeOceanside$11.9M
- Steven MacinaHuntington Beach$11.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.